This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
For an engineer like Rick, who understood the value of evidence and data, it was a revelation. It is sought after because it contains all the cannabinoids (the highest concentrate of THC), terpenes, and other compounds found in the cannabis plant. Something clicked in Rick’s mind.
We are currently recruiting patients, and data-capturing all the questionnaires and feedback from the patients for the live study. What’s more, the soon-to-be-introduced strain is laden with myrcene and beta-caryophyllene terpenes. S tudy subjects must be willing and ready to substitute opioids with cannabis. “We
The Berlin-based company says they are debuting new cannabis extracts for the United Kingdom that meet EU GMP standards and are developed using, “a new extraction process has been developed to ensure the terpene profile of its products consistently remains at a high level,” according to the press release.
“Our primary objective is to be the platform that embodies safety in cannabis through innovative solutions, method development, integrity in reporting, and through advocacy for sensible regulations on behalf of the industry and consumers.”. Inevitably, this drives product development and greater value for brands and consumers.”.
From July 2017 to June 2018, the state saw $529,851,245 in taxable medical and adult-use cannabis sales, a figure that has steadily increased to $719,216,651 during the current fiscal year, which includes sales data from July 2020 to March 2021, according to the Nevada Department of Taxation. They’re flexible and ready to pivot.”.
From July 2017 to June 2018, the state saw $529,851,245 in taxable medical and adult-use cannabis sales, a figure that has steadily increased to $719,216,651 during the current fiscal year, which includes sales data from July 2020 to March 2021, according to the Nevada Department of Taxation. They’re flexible and ready to pivot.”.
From July 2017 to June 2018, the state saw $529,851,245 in taxable medical and adult-use cannabis sales, a figure that has steadily increased to $719,216,651 during the current fiscal year, which includes sales data from July 2020 to March 2021, according to the Nevada Department of Taxation. They’re flexible and ready to pivot.”.
Listen & Subscribe: Israel is world-renowned for the research and innovation that is taking place there, and unofficial data suggests that around 20% of the Israeli population uses cannabis. We do participate in clinical trials that are initiated by others, and we will have our own clinical trial using terpene formulations in oil.
From July 2017 to June 2018, the state saw $529,851,245 in taxable medical and adult-use cannabis sales, a figure that has steadily increased to $719,216,651 during the current fiscal year, which includes sales data from July 2020 to March 2021, according to the Nevada Department of Taxation. They’re flexible and ready to pivot.”.
At the same time, the outlook on cannabis research data is largely positive. Research into the plant’s chemical compounds has also revealed a rich array of terpenes and flavonoids that may also account for the plant’s therapeutic effects (Kotsirilos and McGregor 2021 ). Data collection.
I feel like the dust is starting to settle a little bit and you know from the testing angle of it you know kind of looking at the data analytics and the statistics of what we’re seeing you know I have more and more hope and optimism by the day, especially around the idea of cooperative cannabis. They don’t do that!
Today on the show we welcome Nikki Lawley, a Traumatic Brain Injury Survivor, and founder of NIKKI and the Plant, an advocacy group for medical marijuana use, with a special focus on helping women who have suffered a TBI. It’s all about the terpenes for me. EG: Wow, if there’s a bunch of things I want to drill into that story.
Healing Advocacy Fund. Sam is the Executive Director of the Healing Advocacy Fund, which is the nonprofit organization supporting the implementation of Measure 109 in Oregon. Graham contributes to Psilocybin Alpha as editor-at-large, providing data for patent trackers and writing about IP in the psychedelics space. Sam Chapman.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content